Here are the list of selected open-access review of melioidosis
1) Global Burden and Challenges of Melioidosis. 2019
2) Melioidosis. A Century of Observation and Research. 2012
Melioidosis a Century of Observation and Research is a comprehensive monograph published in 2012 on melioidosis since its first description in 1912. Authored by 67 leaders in research and clinical aspects of melioidosis, this monograph is a compendium with sections on: history, epidemiology, microbiology, clinical manifestations, laboratory diagnosis and detection, treatment, pathogenesis and development of protection, veterinary infections, environmental aspects, in addition to a section on other closely related Burkholderia species. Above all, for those investigators commencing work in the growing field of melioidosis and Burkholderia pseudomallei research, it encapsulates the published literature of a century of discoveries.
1) Melioidosis, Nat Rev Dis Primers. 2018
"In the Outlook, we explore future directions of research in the omics and cutting-edge immunology era, argue whether melioidosis should be recognized as a neglected tropical disease and discuss whether a viable vaccine is on the horizon. ..." [Weblink]
2) Genomic Insights into the Melioidosis Pathogen, Burkholderia pseudomallei, Curr Trop Med Rep. 2017
"The review has highlighted the crucial role that genomics has played so far in answering fundamental questions about B.pseudomallei origin, transmission, virulence, within-hostevolution, and antibiotic resistance mechanisms. ..." [Weblink]
3) Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis, Nature Microbiology. 2016
"Our estimates suggest that melioidosis is severely underreported in the 45 countries in which it is known to be endemic and that melioidosis is probably endemic in a further 34 countries that have never reported the disease. ..." [Weblink]
4) Melioidosis: Evolving Concepts in Epidemiology, Pathogenesis, and Treatment, Semin Respir Crit Care Med. 2015
"Melioidosis also has a myriad of other clinical presentations and diagnosis is often delayed because of this and because of difficulties with laboratory diagnosis and lack of recognition outside melioidosis-endemic regions. ..." [Weblink]
5) Treatment and prophylaxis of melioidosis, Int J Antimicrob Agents. 2014
"Treatment is usually divided into two phases: in the first, or acute phase, parenteral drugs are given for ≥10 days with the aim of preventing death from overwhelming sepsis. ..." [Weblink]
6) Systematic Review and Consensus Guidelines for Environmental Sampling of Burkholderia pseuodmallei, PLoS NTD. 2013
"The proposed consensus guidelines provide the basis for the development of an accurate and comprehensive global map of environmental B. pseudomallei. ..." [Weblink]
7) Melioidosis, NEJM. 2012
"Melioidosis, caused by the environmental gram-negative bacillus Burkholderia pseudomallei, is classically characterized by pneumonia and multiple abscesses, with a mortality rate of up to 40%. ..." [Weblink]
8) Melioidosis: a clinical overview, Br Med Bull. 2011
"Areas of controversy whether seroconversion signals the presence of a quiescent bacterial focus and an increase in long-term risk of melioidosis. ...." [Weblink]
9) Melioidosis: Epidemiology, Pathophysiology, and Management, Clin Microbiol Rev. 2005
[Weblink]